Conclusion Based on this systematic review using a modified COSMIN approach, EORTC-BR45/42 and FACT-ES are recommended for assessing HRQoL in breast cancer patients undergoing AET
Those discontinuing GLP-1 medications rapidly regained weight January 14, 2025 Summary: Despite their benefits, many people stop GLP-1 weight loss drugs, sometimes due to lack of coverage
Katie Sorensen, FNP-C, a nurse practitioner and owner of Weight Loss NP.
The drug companies marketed it backwards because lose 15% of your body weight sells better than normalize your insulin signaling and reduce systemic inflammation. But it set up the wrong framework
We then replicated the effect of GLP-1R-based agonists on MASLD in independent datasets to improve the robustness of the results
It is maintaining power, durability and health while training consistently